Adeline Bouche Email

Adeline Bouche Work

• Franchise Head Breast Cancer @ AstraZeneca (April 2025 - Present)
• Global Integrated Strategy Leader | Haematology | Lymphoma (FL, DLBCL, MCL) | Lunsumio® and Columvi® @ Roche (May 2021 - March 2025)
• Global Marketing Leader | Oncology | GI, HCC, CIT | TECENTRIQ® and Tiragolumab, anti-TIGIT @ Roche (September 2018 - May 2021)
• Global International Product Manager | Oncology | BREAST (TnBC) and GI (HCC) | TECENTRIQ® @ Roche (August 2017 - August 2018)
• Group Marketing Leader | Hematology | Lymphoma and Leukemia FL,DLBCL,CLL | MabThera® SC®, GAZYVA® @ Roche (January 2015 - July 2017)
• Finance Business Partner @ Roche (September 2013 - December 2014)
  View Department
• Senior Product Manager | Hematology | Lymphoma and Leukemia FL,DLBCL,CLL | MabThera SC® @ Roche (April 2012 - August 2013)
• Senior Product Manager Hematology | Multiple Myeloma | Velcade® @ Johnson & Johnson Innovative Medicine (February 2010 - February 2012)
• Product manager | Cancer painkiller | Durogesic®-Effentora® @ Johnson & Johnson Innovative Medicine (November 2008 - February 2010)
• Retail Product manager | GI | Pariet® @ Johnson & Johnson Innovative Medicine (January 2007 - October 2008)
• Sales Representative | GI and Neurology | Pariet®, Risperdal®, Reminyl LP® @ Johnson & Johnson Innovative Medicine (January 2006 - December 2006)
• Internship | Retail product manager | Ketoderm® Durogesic® Actiq® @ Johnson & Johnson Innovative Medicine (April 2004 - December 2005)